<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35627530</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>15</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>Clinical and Socio-Demographic Variables Associated with the Diagnosis of Long COVID Syndrome in Youth: A Population-Based Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5993</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph19105993</ELocationID><Abstract><AbstractText>This study examines the demographic, clinical and socioeconomic factors associated with diagnosis of long COVID syndrome (LCS). Data of 20,601 COVID-19-positive children aged 5 to 18 years were collected between 2020 and 2021 in an Israeli database. Logistic regression analysis was used to evaluate the adjusted odds ratio for the characteristics of the COVID-19 infection and pre-COVID-19 morbidities. Children with LCS were significantly more likely to have been severely symptomatic, required hospitalization, and experienced recurrent acute infection within 180 days. In addition, children with LCS were significantly more likely to have had ADHD, chronic urticaria, and allergic rhinitis. Diagnosis of LCS is significantly associated with pre-COVID-19 ADHD diagnosis, suggesting clinicians treating ADHD children who become infected with COVID-19 remain vigilant for the possibility of LCS. Although the risk of severe COVID-19 infection and LCS in children is low, further research on possible morbidity related to LCS in children is needed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Merzon</LastName><ForeName>Eugene</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Leumit Health Services, Tel-Aviv 6473817, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Adelson School of Medicine, Ariel University, Ariel 4076414, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiss</LastName><ForeName>Margaret</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8153-8213</Identifier><AffiliationInfo><Affiliation>Cambridge Health Alliance, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krone</LastName><ForeName>Beth</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-4046-8305</Identifier><AffiliationInfo><Affiliation>Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cohen</LastName><ForeName>Shira</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>ADHD Unit, Geha Mental Health Center, Petah Tikva 49100, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ilani</LastName><ForeName>Gili</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vinker</LastName><ForeName>Shlomo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Leumit Health Services, Tel-Aviv 6473817, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Family Medicine, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cohen-Golan</LastName><ForeName>Avivit</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Leumit Health Services, Tel-Aviv 6473817, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Family Medicine, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Green</LastName><ForeName>Ilan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Leumit Health Services, Tel-Aviv 6473817, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Family Medicine, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Israel</LastName><ForeName>Ariel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Leumit Health Services, Tel-Aviv 6473817, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Tzipporah</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Clalit Health Services, Bnei Brak 5111501, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashkenazi</LastName><ForeName>Shai</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7244-0679</Identifier><AffiliationInfo><Affiliation>Adelson School of Medicine, Ariel University, Ariel 4076414, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weizman</LastName><ForeName>Abraham</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9765-8938</Identifier><AffiliationInfo><Affiliation>ADHD Unit, Geha Mental Health Center, Petah Tikva 49100, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manor</LastName><ForeName>Iris</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>ADHD Unit, Geha Mental Health Center, Petah Tikva 49100, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001289" MajorTopicYN="Y">Attention Deficit Disorder with Hyperactivity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009017" MajorTopicYN="N">Morbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013577" MajorTopicYN="N">Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ADHD</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">morbidity</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>28</Day><Hour>1</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35627530</ArticleId><ArticleId IdType="pmc">PMC9141083</ArticleId><ArticleId IdType="doi">10.3390/ijerph19105993</ArticleId><ArticleId IdType="pii">ijerph19105993</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aiyegbusi O.L., Hughes S.E., Turner G., Rivera S.C., Mcmullan C., Chandan J.S., Haroon S., Price G., Davies E.H., Nirantharakumar K., et al. Symptoms, complications and management of long COVID: A review. J. R. Soc. Med. 2021;114:428&#x2013;442. doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell M.L., Catalfamo C.J., Farland L.V., Ernst K.C., Jacobs E.T., Klimentidis Y.C., Jehn M., Pogreba-Brown K. Post-acute sequelae of COVID-19 in a non-hospitalized cohort: Results from the Arizona CoVHORT. PLoS ONE. 2021;16:e0254347. doi: 10.1371/journal.pone.0254347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254347</ArticleId><ArticleId IdType="pmc">PMC8336814</ArticleId><ArticleId IdType="pubmed">34347785</ArticleId></ArticleIdList></Reference><Reference><Citation>Buitrago-Garcia D., Egli-Gany D., Counotte M.J., Hossmann S., Imeri H., Ipekci A.M., Salanti G., Low N. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis. PLoS Med. 2020;17:e1003346. doi: 10.1371/journal.pmed.1003346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003346</ArticleId><ArticleId IdType="pmc">PMC7508369</ArticleId><ArticleId IdType="pubmed">32960881</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker H.R., Gulea C., Koteci A., Kallis C., Morgan A.D., Iwundu C., Weeks M., Gupta R., Quint J.K. GP consultation rates for sequelae after acute COVID-19 in patients managed in the community or hospital in the UK: Population based study. BMJ Clin. Res. Ed. 2021;375:e065834. doi: 10.1136/bmj-2021-065834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-065834</ArticleId><ArticleId IdType="pmc">PMC8715128</ArticleId><ArticleId IdType="pubmed">34965929</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta S.D., Talwar A., Lee J.T. A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: Illness beyond acute infection and public health implications. JAMA. 2020;324:2251&#x2013;2252. doi: 10.1001/jama.2020.22717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.22717</ArticleId><ArticleId IdType="pubmed">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e820. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Ram-Mohan N., Kim D., Zudock E.J., Hashemi M.M., Tjandra K.C., Rogers A.J., Blish C.A., Nadeau K.C., Newberry J.A., Quinn J.V., et al. SARS-CoV-2 RNAemia predicts clinical deterioration and extrapulmonary complications from COVID-19. Clin. Infect. Dis. 2022;74:218&#x2013;226. doi: 10.1093/cid/ciab394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab394</ArticleId><ArticleId IdType="pmc">PMC8135992</ArticleId><ArticleId IdType="pubmed">33949665</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Florencio L.L., G&#xf3;mez-Mayordomo V., Cuadrado M.L., Palacios-Ce&#xf1;a D., Raveendran A.V. Proposed integrative model for post-COVID symptoms. Diabetes Metab. Syndr. 2021;15:102159. doi: 10.1016/j.dsx.2021.05.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.05.032</ArticleId><ArticleId IdType="pmc">PMC8168334</ArticleId><ArticleId IdType="pubmed">34186367</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghimi N., Di Napoli M., Biller J., Siegler J.E., Shekhar R., McCullough L.D., Harkins M.S., Hong E., Alaouieh D.A., Mansueto G., et al. The neurological manifestations of post-acute sequelae of SARS-CoV-2 infection. Curr. Neurol. Neurosci. Rep. 2021;21:44. doi: 10.1007/s11910-021-01130-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-021-01130-1</ArticleId><ArticleId IdType="pmc">PMC8237541</ArticleId><ArticleId IdType="pubmed">34181102</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai A.D., Lavelle M., Boursiquot B.C., Wan E.Y. Long-term complications of COVID-19. Am. J. Physiol. Cell Physiol. 2022;322:C1&#x2013;C11. doi: 10.1152/ajpcell.00375.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00375.2021</ArticleId><ArticleId IdType="pmc">PMC8721906</ArticleId><ArticleId IdType="pubmed">34817268</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  A Clinical Case Definition of Post COVID Condition by a Delphi Consensus.  [(accessed on 26 January 2022)].  Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long COVID-mechanisms, risk factors, and management. BMJ Clin. Res. Ed. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O., Merino E., Leon-Ramirez J.M., Andres M., Ramos J.M., Arenas-Jim&#xe9;nez J., Asensio S., Sanchez R., Ruiz-Torregrosa P., Galan I., et al. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J. Infect. 2021;82:378&#x2013;383. doi: 10.1016/j.jinf.2021.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabacof L., Tosto-Mancuso J., Wood J., Cortes M., Kontorovich A., McCarthy D., Rizk D., Rozanski G., Breyman E., Nasr L., et al. Post-acute COVID-19 syndrome negatively impacts physical function, cognitive function, health-related quality of life, and participation. Am. J. Phys. Med. Rehabil. 2022;101:48&#x2013;52. doi: 10.1097/PHM.0000000000001910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001910</ArticleId><ArticleId IdType="pmc">PMC8667685</ArticleId><ArticleId IdType="pubmed">34686631</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M., Schommers P., Stecher M., Dewald F., Gieselmann L., Gruell H., Horn C., Vanshylla K., Cristanziano V.D., Osebold L., et al. Recovered not restored: Long-term health consequences after mild COVID-19 in non-hospitalized patients. medRxiv. 2021 doi: 10.1101/2021.03.11.21253207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.11.21253207</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin S., O&#x2019;Connor R., Sivan M. Long COVID and chronic COVID syndromes. J. Med. Virol. 2021;93:1242&#x2013;1243. doi: 10.1002/jmv.26587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26587</ArticleId><ArticleId IdType="pmc">PMC7675759</ArticleId><ArticleId IdType="pubmed">33034893</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams M.L., Katz D.L., Grandpre J. Population-based estimates of chronic conditions affecting risk for complications from coronavirus disease, United States. Emerg. Infect. Dis. 2020;26:1831&#x2013;1833. doi: 10.3201/eid2608.200679.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2608.200679</ArticleId><ArticleId IdType="pmc">PMC7392427</ArticleId><ArticleId IdType="pubmed">32324118</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang W., Guan W., Chen R., Wang W., Li J., Xu K., Li C., Ai Q., Lu W., Liang H., et al. Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China. Lancet Oncol. 2020;21:335&#x2013;337. doi: 10.1016/S1470-2045(20)30096-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(20)30096-6</ArticleId><ArticleId IdType="pmc">PMC7159000</ArticleId><ArticleId IdType="pubmed">32066541</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson J.F. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109:1088&#x2013;1095. doi: 10.1111/apa.15270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15270</ArticleId><ArticleId IdType="pmc">PMC7228328</ArticleId><ArticleId IdType="pubmed">32202343</ArticleId></ArticleIdList></Reference><Reference><Citation>Castagnoli R., Votto M., Licari A., Brambilla I., Bruno R., Perlini S., Rovida F., Baldanti F., Marseglia G.L. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review. JAMA Pediatr. 2020;174:882&#x2013;889. doi: 10.1001/jamapediatrics.2020.1467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2020.1467</ArticleId><ArticleId IdType="pubmed">32320004</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P., Pittet L.F., Curtis N. Long COVID in children and adolescents. BMJ Clin. Res. Ed. 2022;376:o143. doi: 10.1136/bmj.o143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o143</ArticleId><ArticleId IdType="pubmed">35058281</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Munblit D., De Rose C., Sinatti D., Ricchiuto A., Carfi A., Valentini P. Preliminary evidence on long COVID in children. Acta Paediatr. 2021;110:2208&#x2013;2211. doi: 10.1111/apa.15870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15870</ArticleId><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson J.F. Convulsions in children with COVID-19 during the Omicron wave. Acta Paediatr. 2022;111:1023&#x2013;1026. doi: 10.1111/apa.16276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.16276</ArticleId><ArticleId IdType="pmc">PMC9303202</ArticleId><ArticleId IdType="pubmed">35098577</ArticleId></ArticleIdList></Reference><Reference><Citation>LaRovere K.L., Riggs B.J., Poussaint T.Y., Young C.C., Newhams M.M., Maamari M., Walker T.C., Singh A.R., Dapul H., Hobbs C.V., et al. Neurologic involvement in children and adolescents hospitalized in the United States for COVID-19 or multisystem inflammatory syndrome. JAMA Neurol. 2021;78:536&#x2013;547. doi: 10.1001/jamaneurol.2021.0504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.0504</ArticleId><ArticleId IdType="pmc">PMC7936352</ArticleId><ArticleId IdType="pubmed">33666649</ArticleId></ArticleIdList></Reference><Reference><Citation>Merzon E., Manor I., Rotem A., Schneider T., Vinker S., Golan Cohen A., Lauden A., Weizman A., Green I. ADHD as a risk factor for infection with COVID-19. J. Atten. Disord. 2021;25:1783&#x2013;1790. doi: 10.1177/1087054720943271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1087054720943271</ArticleId><ArticleId IdType="pmc">PMC8427814</ArticleId><ArticleId IdType="pubmed">32697120</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Xu R., Volkow N.D. Increased risk of COVID-19 infection and mortality in people with mental disorders: Analysis from electronic health records in the United States. World Psychiatry. 2021;20:124&#x2013;130. doi: 10.1002/wps.20806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.20806</ArticleId><ArticleId IdType="pmc">PMC7675495</ArticleId><ArticleId IdType="pubmed">33026219</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuelscher I., Hyde C., Anderson V., Silk T.J. White matter tract signatures of fiber density and morphology in ADHD. Cortex J. Devoted Study Nerv. Syst. Behav. 2021;138:329&#x2013;340. doi: 10.1016/j.cortex.2021.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cortex.2021.02.015</ArticleId><ArticleId IdType="pubmed">33784515</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D., Cui X., Yan T., Liu B., Zhang H., Xiang J., Wang B. Abnormal rich club organization in hemispheric white matter networks of ADHD. J. Atten. Disord. 2021;25:1215&#x2013;1229. doi: 10.1177/1087054719892887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1087054719892887</ArticleId><ArticleId IdType="pubmed">31884863</ArticleId></ArticleIdList></Reference><Reference><Citation>American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders: DSM-5. American Psychiatric Association; Arlington, VA, USA: 2013.</Citation></Reference><Reference><Citation>Merikangas K.R., He J.P., Brody D., Fisher P.W., Bourdon K., Koretz D.S. Prevalence and treatment of mental disorders among US children in the 2001&#x2013;2004 NHANES. Pediatrics. 2010;125:75&#x2013;81. doi: 10.1542/peds.2008-2598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2008-2598</ArticleId><ArticleId IdType="pmc">PMC2938794</ArticleId><ArticleId IdType="pubmed">20008426</ArticleId></ArticleIdList></Reference><Reference><Citation>Larson K., Russ S.A., Kahn R.S., Halfon N. Patterns of comorbidity, functioning, and service use for US children with ADHD, 2007. Pediatrics. 2011;127:462&#x2013;470. doi: 10.1542/peds.2010-0165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2010-0165</ArticleId><ArticleId IdType="pmc">PMC3065146</ArticleId><ArticleId IdType="pubmed">21300675</ArticleId></ArticleIdList></Reference><Reference><Citation>Instanes J.T., Klungs&#xf8;yr K., Halm&#xf8;y A., Fasmer O.B., Haavik J. Adult ADHD and Comorbid Somatic Disease: A Systematic Literature Review. J. Atten. Disord. 2018;22:203&#x2013;228. doi: 10.1177/1087054716669589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1087054716669589</ArticleId><ArticleId IdType="pmc">PMC5987989</ArticleId><ArticleId IdType="pubmed">27664125</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan P.-Y., B&#xf6;lte S. The association between ADHD and physical health: A co-twin control study. Sci. Rep. 2020;10:22388. doi: 10.1038/s41598-020-78627-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-78627-1</ArticleId><ArticleId IdType="pmc">PMC7769983</ArticleId><ArticleId IdType="pubmed">33372183</ArticleId></ArticleIdList></Reference><Reference><Citation>Fasmer O.B., Riise T., Eagan T.M., Lund A., Dilsaver S.C., Hundal O., Oedegaard K.J. Comorbidity of asthma with ADHD. J. Atten. Disord. 2011;15:564&#x2013;571. doi: 10.1177/1087054710372493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1087054710372493</ArticleId><ArticleId IdType="pubmed">20574059</ArticleId></ArticleIdList></Reference><Reference><Citation>Strom M.A., Fishbein A.B., Paller A.S., Silverberg J.I. Association between atopic dermatitis and attention deficit hyperactivity disorder in U.S. children and adults. Br. J. Dermatol. 2016;175:920&#x2013;929. doi: 10.1111/bjd.14697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjd.14697</ArticleId><ArticleId IdType="pmc">PMC5216180</ArticleId><ArticleId IdType="pubmed">27105659</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn D.W., Austin J.K., Harezlak J., Ambrosius W.T. ADHD and epilepsy in childhood. Dev. Med. Child. Neurol. 2003;45:50&#x2013;54. doi: 10.1111/j.1469-8749.2003.tb00859.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-8749.2003.tb00859.x</ArticleId><ArticleId IdType="pubmed">12549755</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D.J., Chen Y.L., Hsiao R.C., Chen H.L., Yen C.F. Risk of respiratory infectious diseases and the role of methylphenidate in children with Attention-Deficit/Hyperactivity Disorder: A population-based cohort study. Int. J. Environ. Res. Public Health. 2021;18:5824. doi: 10.3390/ijerph18115824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18115824</ArticleId><ArticleId IdType="pmc">PMC8199289</ArticleId><ArticleId IdType="pubmed">34071586</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen H.A., Gerstein M., Yaniv N., Richenberg Y., Jacobson E., Marton S., Hoshen M., Shkalim Zemer V. Attention-Deficit/Hyperactivity Disorder as a Risk Factor for COVID-19 Infection. J. Atten. Disord. 2021;26:10870547211044217. doi: 10.1177/10870547211044217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10870547211044217</ArticleId><ArticleId IdType="pubmed">34668429</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu N., Tan J.-S., Liu L., Wang Y., Hua L., Qian Q. Genetic predisposition between COVID-19 and four mental illnesses: A bidirectional, two-sample mendelian randomization study. Front. Psychiatry. 2021;12:746276. doi: 10.3389/fpsyt.2021.746276.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.746276</ArticleId><ArticleId IdType="pmc">PMC8564104</ArticleId><ArticleId IdType="pubmed">34744839</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanyaolu A., Okorie C., Marinkovic A., Patidar R., Younis K., Desai P., Hosein Z., Padda I., Mangat J., Altaf M. Comorbidity and its impact on patients with COVID-19. SN Compr. Clin. Med. 2020;2:1069&#x2013;1076. doi: 10.1007/s42399-020-00363-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00363-4</ArticleId><ArticleId IdType="pmc">PMC7314621</ArticleId><ArticleId IdType="pubmed">32838147</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Y., Wu J., Chen T., Li J., Zhang G., Wu D., Zhou Y., Zheng N., Cai A., Ning Q., et al. Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations. J. Clin. Investig. 2021;131 doi: 10.1172/JCI147329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI147329</ArticleId><ArticleId IdType="pmc">PMC8262559</ArticleId><ArticleId IdType="pubmed">33630760</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn G.A., Nigg J.T., Sullivan E.L. Neuroinflammation as a risk factor for attention deficit hyperactivity disorder. Pharmacol. Biochem. Behav. 2019;182:22&#x2013;34. doi: 10.1016/j.pbb.2019.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pbb.2019.05.005</ArticleId><ArticleId IdType="pmc">PMC6855401</ArticleId><ArticleId IdType="pubmed">31103523</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., Lange F., Andersson J.L.R., Griffanti L., Duff E., et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. medRxiv. 2022 doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Makris N., Buka S.L., Biederman J., Papadimitriou G.M., Hodge S.M., Valera E.M., Brown A.B., Bush G., Monuteaux M.C., Caviness V.S., et al. Attention and executive systems abnormalities in adults with childhood ADHD: A DT-MRI study of connections. Cereb. Cortex. 2008;18:1210&#x2013;1220. doi: 10.1093/cercor/bhm156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhm156</ArticleId><ArticleId IdType="pubmed">17906338</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S., Zhou Z., Yang D., Zhao W., Zeng M., Xie X., Du Y., Jiang Y., Zhou X., Yang W., et al. Persistent white matter changes in recovered COVID-19 patients at the 1-year follow-up. Brain. 2021 doi: 10.1093/brain/awab435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab435</ArticleId><ArticleId IdType="pmc">PMC8754808</ArticleId><ArticleId IdType="pubmed">34918020</ArticleId></ArticleIdList></Reference><Reference><Citation>Albajara S&#xe1;enz A., Villemonteix T., Slama H., Baijot S., Mary A., Bal&#xe9;riaux D., Metens T., Kavec M., Peigneux P., Massat I. Relationship between white matter abnormalities and neuropsychological measures in children with ADHD. J. Atten. Disord. 2020;24:1020&#x2013;1031. doi: 10.1177/1087054718787878.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1087054718787878</ArticleId><ArticleId IdType="pubmed">30014760</ArticleId></ArticleIdList></Reference><Reference><Citation>Connaughton M., Whelan R., O&#x2019;Hanlon E., McGrath J. White matter microstructure in children and adolescents with ADHD. NeuroImage Clin. 2022;33:102957. doi: 10.1016/j.nicl.2022.102957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2022.102957</ArticleId><ArticleId IdType="pmc">PMC8842077</ArticleId><ArticleId IdType="pubmed">35149304</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Agati E., Casarelli L., Pitzianti M.B., Pasini A. Overflow movements and white matter abnormalities in ADHD. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2010;34:441&#x2013;445. doi: 10.1016/j.pnpbp.2010.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2010.01.013</ArticleId><ArticleId IdType="pubmed">20100533</ArticleId></ArticleIdList></Reference><Reference><Citation>Saad J.F., Griffiths K.R., Kohn M.R., Braund T.A., Clarke S., Williams L.M., Korgaonkar M.S. No support for white matter connectivity differences in the combined and inattentive ADHD presentations. PLoS ONE. 2021;16:e0245028. doi: 10.1371/journal.pone.0245028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0245028</ArticleId><ArticleId IdType="pmc">PMC8099057</ArticleId><ArticleId IdType="pubmed">33951031</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai C.J., Lin H.Y., Tseng I.W., Gau S.S. White matter microstructural integrity correlates of emotion dysregulation in children with ADHD: A diffusion imaging tractography study. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2021;110:110325. doi: 10.1016/j.pnpbp.2021.110325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2021.110325</ArticleId><ArticleId IdType="pubmed">33857524</ArticleId></ArticleIdList></Reference><Reference><Citation>Versace A., Jones N.P., Joseph H.M., Lindstrom R.A., Wilson T.K., Lima Santos J.P., Gnagy E.M., Pelham W.E., Jr., Ladouceur C.D., Molina B.S.G. White matter abnormalities associated with ADHD outcomes in adulthood. Mol. Psychiatry. 2021;26:6655&#x2013;6665. doi: 10.1038/s41380-021-01153-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-021-01153-7</ArticleId><ArticleId IdType="pmc">PMC8613296</ArticleId><ArticleId IdType="pubmed">34035475</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z.M., Wang P., Yang L., Liu L., Sun L., An L., Cao Q.J., Chan R.C.K., Yang B.R., Wang Y.F. Altered brain white matter microstructural asymmetry in children with ADHD. Psychiatry Res. 2020;285:112817. doi: 10.1016/j.psychres.2020.112817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2020.112817</ArticleId><ArticleId IdType="pubmed">32035376</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Yang L., Gong G., Cao Q., Liu J. Identify aberrant white matter microstructure in ASD, ADHD and other neurodevelopmental disorders: A meta-analysis of diffusion tensor imaging studies. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2022;113:110477. doi: 10.1016/j.pnpbp.2021.110477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2021.110477</ArticleId><ArticleId IdType="pubmed">34798202</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham E., Ren A., Digby R., Outtrim J., Chatfield D., Manktelow A., Newcombe V., Doffinger R., Barcenas-Morales G., Fonseca C., et al. Brain Injury in COVID-19 is associated with autoinflammation and autoimmunity. medRxiv. 2021 doi: 10.1101/2021.12.03.21266112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.12.03.21266112</ArticleId></ArticleIdList></Reference><Reference><Citation>Passarelli F., Donfrancesco R., Nativio P., Pascale E., Di Trani M., Patti A.M., Vulcano A., Gozzo P., Villa M.P. Anti-Purkinje cell antibody as a biological marker in attention deficit/hyperactivity disorder: A pilot study. J. Neuroimmunol. 2013;258:67&#x2013;70. doi: 10.1016/j.jneuroim.2013.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2013.02.018</ArticleId><ArticleId IdType="pubmed">23510584</ArticleId></ArticleIdList></Reference><Reference><Citation>Donfrancesco R., Nativio P., Borrelli E., Giua E., Andriola E., Villa M.P., Trani M.D.I. Serum cytokines in pediatric neuropsychiatric syndromes: Focus on Attention Deficit Hyperactivity Disorder. Minerva Pediatr. 2021;73:398&#x2013;404. doi: 10.23736/S2724-5276.16.04642-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S2724-5276.16.04642-9</ArticleId><ArticleId IdType="pubmed">28006890</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams J., Burgess S., Suckling J., Lalousis P.A., Batool F., Griffiths L., Palmer E., Karwath A., Barsky A., Gkoutos G.V., et al. Inflammation and brain structure in schizophrenia and other neuropsychiatric disorders: An interrogation of causal pathways and transcriptomic profiles. JAMA Psychiatry. 2022;79:498&#x2013;507. doi: 10.1001/jamapsychiatry.2022.0407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2022.0407</ArticleId><ArticleId IdType="pmc">PMC8968718</ArticleId><ArticleId IdType="pubmed">35353173</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J., Zhou F., Hou W., Silver Z., Wong C.Y., Chang O., Huang E., Zuo Q.K. The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: A meta-analysis. Ann. N. Y. Acad. Sci. 2021;1486:90&#x2013;111. doi: 10.1111/nyas.14506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.14506</ArticleId><ArticleId IdType="pmc">PMC7675607</ArticleId><ArticleId IdType="pubmed">33009668</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov I.M., Spiridonova E., Bobkova P., Gamirova A., Shikhaleva A., Andreeva M., Blyuss O., El-Taravi Y., DunnGalvin A., Comberiati P., et al. Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: A prospective cohort study. Eur. Respir. J. 2022;59:2101341. doi: 10.1183/13993003.01341-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01341-2021</ArticleId><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren J., Pang W., Luo Y., Cheng D., Qiu K., Rao Y., Zheng Y., Dong Y., Peng J., Hu Y., et al. Impact of allergic rhinitis and asthma on COVID-19 infection, hospitalization, and mortality. J. Allergy Clin. Immunol. Pract. 2022;10:124&#x2013;133. doi: 10.1016/j.jaip.2021.10.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2021.10.049</ArticleId><ArticleId IdType="pmc">PMC8556867</ArticleId><ArticleId IdType="pubmed">34728408</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagemann J., Onorato G.L., Jutel M., Akdis C.A., Agache I., Zuberbier T., Czarlewski W., Mullol J., Bedbrook A., Bachert C., et al. Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus. Allergy. 2021;76:2354&#x2013;2366. doi: 10.1111/all.14815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14815</ArticleId><ArticleId IdType="pmc">PMC8250633</ArticleId><ArticleId IdType="pubmed">33730365</ArticleId></ArticleIdList></Reference><Reference><Citation>Gani F., Cottini M., Landi M., Berti A., Comberiati P., Peroni D., Senna G., Lombardi C. Allergic rhinitis and COVID-19: Friends or foes? Eur. Ann. Allergy Clin. Immunol. 2022;54:53&#x2013;59. doi: 10.23822/EurAnnACI.1764-1489.234.</Citation><ArticleIdList><ArticleId IdType="doi">10.23822/EurAnnACI.1764-1489.234</ArticleId><ArticleId IdType="pubmed">34503647</ArticleId></ArticleIdList></Reference><Reference><Citation>Bostan E., Zaid F., Karaduman A., Dogan S., Gulseren D., Yalici-Armagan B., Akdogan N., Ersoy-Evans S., Elcin G. The effect of COVID-19 on patients with chronic spontaneous urticaria treated with omalizumab and antihistamines: A cross-sectional, comparative study. J. Cosmet. Dermatol. 2021;20:3369&#x2013;3375. doi: 10.1111/jocd.14484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocd.14484</ArticleId><ArticleId IdType="pmc">PMC8661558</ArticleId><ArticleId IdType="pubmed">34599630</ArticleId></ArticleIdList></Reference><Reference><Citation>Atayik E., Aytekin G. The course of COVID-19 in patients with chronic spontaneous urticaria receiving omalizumab treatment. medRxiv. 2022 doi: 10.1101/2022.01.29.22270077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.29.22270077</ArticleId><ArticleId IdType="pmc">PMC9189112</ArticleId><ArticleId IdType="pubmed">35721324</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>